Both in Pharmaceuticals
Madrigal Pharmaceuticals vs Arrowhead Research
Over the past year MDGL returned −3.9% and ARWR returned +50.3%; their daily moves had a correlation of 0.24.
MDGL −3.9% ARWR +50.3%Growth of $1, one year, split-adjusted
| Metric | MDGL | ARWR |
|---|---|---|
| Price | $396.32 | $59.53 |
| Market cap | $9.16B | $8.41B |
| Today | −8.08% | −0.07% |
| 1 month | −19.7% | −4.5% |
| 6 months | −21.1% | −20.6% |
| Year to date | −31.9% | −10.3% |
| 1 year | −5.4% | +40.4% |
| Revenue growth (YoY) | +71.2% | +171.0% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −15.9% | −258.2% |
| P/E (TTM) | — | — |
| Price / sales | 7.1× | 12.6× |
| Net cash | $498.0M | $737.9M |
| Dividend yield | — | — |
| Volatility (60d) | 35.1% | 45.1% |
| Short % of float | 14.7% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).